171 related articles for article (PubMed ID: 22868238)
1. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer.
Renouf DJ; Woods R; Speers C; Hay J; Phang PT; Fitzgerald C; Kennecke H
Am J Clin Oncol; 2013 Dec; 36(6):558-64. PubMed ID: 22868238
[TBL] [Abstract][Full Text] [Related]
2. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
5. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
[TBL] [Abstract][Full Text] [Related]
6. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
[TBL] [Abstract][Full Text] [Related]
7. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
8. Oncologic outcomes and perioperative clinicopathologic results after robot-assisted tumor-specific mesorectal excision for rectal cancer.
Baik SH; Kim NK; Lim DR; Hur H; Min BS; Lee KY
Ann Surg Oncol; 2013 Aug; 20(8):2625-32. PubMed ID: 23417433
[TBL] [Abstract][Full Text] [Related]
9. Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.
Loree JM; Kennecke HF; Renouf DJ; Lim HJ; Vickers MM; Speers CH; Cheung WY
Clin Colorectal Cancer; 2016 Dec; 15(4):352-359.e1. PubMed ID: 27265355
[TBL] [Abstract][Full Text] [Related]
10. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
[TBL] [Abstract][Full Text] [Related]
11. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
12. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment.
van Gijn W; Krijnen P; Lemmens VE; den Dulk M; Putter H; van de Velde CJ
Eur J Surg Oncol; 2010 Apr; 36(4):340-4. PubMed ID: 19944552
[TBL] [Abstract][Full Text] [Related]
13. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Tanaka Y; Masuda T; Mukoyama S; Yasuda S; Tajima T; Makuuchi H; Murayama C
Hepatogastroenterology; 2003; 50(53):1362-6. PubMed ID: 14571738
[TBL] [Abstract][Full Text] [Related]
14. Outcome for stage II and III rectal and colon cancer equally good after treatment improvement over three decades.
Fischer J; Hellmich G; Jackisch T; Puffer E; Zimmer J; Bleyl D; Kittner T; Witzigmann H; Stelzner S
Int J Colorectal Dis; 2015 Jun; 30(6):797-806. PubMed ID: 25922143
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
16. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
17. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
18. Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery.
Xu J; Zhong Y; Weixin N; Xinyu Q; Yanhan L; Li R; Jianhua W; Zhiping Y; Jiemin C
Ann Surg; 2007 Apr; 245(4):583-90. PubMed ID: 17414607
[TBL] [Abstract][Full Text] [Related]
19. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW
Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
